title: Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism.
abstract: This study focuses on the development of single dose vaccines based on biodegradable polyanhydride microspheres that have the unique capability to modulate the immune response mechanism. The polymer system employed consists of copolymers of 1,6-bis(p-carboxyphenoxy)hexane and sebacic acid. Two copolymer formulations that have been shown to provide extended release kinetics and protein stability were investigated. Using tetanus toxoid (TT) as a model antigen, in vivo studies in C3H/HeOuJ mice demonstrated that the encapsulation procedure preserves the immunogenicity of the TT. The polymer itself exhibited an adjuvant effect, enhancing the immune response to a small dose of TT. The microspheres provided a prolonged exposure to TT sufficient to induce both a primary and a secondary immune response (i.e., high antibody titers) with high-avidity antibody production, without requiring an additional administration. Antigen-specific proliferation 28 weeks after a single immunization indicated that immunization with the polyanhydride microspheres generated long-lived memory cells and plasma cells (antibody-secreting B cells) that generally do not occur without maturation signals from T helper cells. Furthermore, by altering the vaccine formulation, the overall strength of the T helper type 2 immune response was selectively diminished, resulting in a balanced immune response, without reducing the overall titer. This result is striking, considering free TT induces a T helper type 2 immune response, and has important implications for developing vaccines to intracellular pathogens. The ability to selectively tune the immune response without the administration of additional cytokines or noxious adjuvants is a unique feature of this delivery vehicle that may make it an excellent candidate for vaccine development.
authors.affiliation: Department of Chemical and Biological Engineering, Iowa State University, 2035 Sweeney Hall, Ames, 50011-2230, USA.
authors.forename: Matt J
authors.initials: MJ
authors.lastname: Kipper
authors.forename: Jennifer H
authors.initials: JH
authors.lastname: Wilson
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Wannemuehler
authors.forename: Balaji
authors.initials: B
authors.lastname: Narasimhan
mesh_terms: D000818:Animals; D000915:Antibody Affinity; D001672:Biocompatible Materials; D001673:Biodegradation, Environmental; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008863:Microspheres; D013745:Tetanus Toxoid / Q000008:administration & dosage* / Q000276:immunology
chemical_list: D001672:Biocompatible Materials; D013745:Tetanus Toxoid